November 13, 2014

Pharmacists can make use of a suite of resources on Ebola virus specifically designed for those who work in the community sector as of Thursday.

November 3, 2014

A potentially breathable, respiratory vaccine in development has been shown to provide long-term protection for nonhuman primates against the Ebola virus.

 

October 31, 2014

The response to the current global Ebola scare from both the pharmaceutical and pharmacy industries has been nothing short of remarkable. Precautionary preparations have been made to address the Ebola concerns in the United States; several pharmaceutical manufacturers have been working around the clock toward an Ebola vaccine and treatment; and there has been an outpooring of goods that have been directed to help with the outbreak in West Africa. 

Ebola is not a problem in the United States, at least not yet (nor hopefully will it ever be), but the pharmaceutical community is stepping up to help around the world. And in the U.S., there is much being done to help the pharmacy world prepare.

 

October 31, 2014

As many as 62% of attendees at the Academy of Integrative Health & Medicine annual conference this week said that the most important factor in stopping Ebola in the United States is controlling the virus and caring for afflicted patients in West Africa.

October 28, 2014

The Retail Orphan Initiative on Tuesday hosted a webinar detailing a major charitable campaign to fight Ebola in Liberia.

October 27, 2014

Responding to the Ebola virus epidemic, the Retail Orphan Initiative on Monday announced a major campaign to help fight Ebola in Liberia. 

October 27, 2014

Rx Response moved to alert status in response to the concern about Ebola in the United States.

October 22, 2014

The pharmaceutical industry has committed considerable resources to developing both vaccines and treatments to address the current Ebola crisis.

 

October 16, 2014
AdAge on Thursday attributed higher sales of hand sanitizer and disinfectants to the rise in Ebola-related media reports.
October 14, 2014

Cardinal Health on Tuesday announced it had recently donated more than 1 million products to AmeriCares Emergency Response Program to help contain the deadly Ebola outbreak in West Africa. 

October 9, 2014

At a time when nearly every media outlet is covering Ebola, Enterovirus D-68, or a new outbreak of an infectious disease, the American Pharmacists Association is reminding Americans that the nation’s pharmacists are ready to help.

October 8, 2014

The dietary supplement industry on Tuesday spoke out against any supplement manufacturer making advertising claims around the Ebola virus.

October 7, 2014

Biopharmaceutical company Chimerix on Monday announced that brincidofovir has been provided for potential use in patients with Ebola virus at the request of treating physicians.

October 3, 2014

Biolife is helping to combat the Ebola issue with the donation of its WoundSeal product, which helps stop bleeding and seals wounds, to Africa, according to a report from ABC affiliate WWSB

 

September 30, 2014

Johnson & Johnson on Tuesday announced a definitive agreement to acquire Alios BioPharma, a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.8 billion in cash.

August 21, 2014

Hospitals and state laboratories in the United States have processed more than 60 Ebola scares over the course of the last few weeks, according to a report from ABC News.

 

August 7, 2014

A new experimental drug to treat Ebola has been tried in the two American patients being treated in an Atlanta hospital, The New York Times reported Wednesday

August 5, 2014

New York City's Department of Health and Mental Hygiene said a man who was tested for Ebola at Mount Sinai Hospital is "unlikely" to have the virus. The patient was admitted to the hospital early Monday with a fever and gastrointestinal problems. He recently visited a West African country where Ebola was reported, according to the Washington Post.

June 30, 2014

In response to the increasing number of measles and mumps cases, and under Ohio Governor John Kasich's emergency order, Rite Aid pharmacists across Ohio now are able to administer the MMR (measles, mumps and rubella) vaccine to adults ages 18 years and older.

June 18, 2014

In response to an executive order recently signed by Gov. John R. Kasich authorizing licensed pharmacists in Ohio to administer the measles, mumps and rubella vaccine to patients, all of the more than 250 Walgreens pharmacies and 35 Healthcare Clinics at select Walgreens throughout Ohio are now offering MMR vaccinations daily with no appointment necessary.

June 11, 2014

Responding to the recent outbreaks of mumps and measles in Ohio, Gov. John R. Kasich has signed an executive order authorizing licensed pharmacists to administer the measles, mumps, and rubella vaccine to patients ages 18 years and older.

June 10, 2014

Ohio Gov. John Kasich on Monday signed executive order 2014-04K authorizing licensed pharmacists to administer the measles, mumps, and rubella (MMR) vaccine to individuals 18 years and older in order to provide those adults who have not yet received this vaccination with additional opportunities to obtain the MMR vaccine.

April 25, 2014

The Centers for Disease Control and Prevention on Thursday reported that vaccinations will prevent more than 21 million hospitalizations and more than 700,000 deaths among children born in the last two decades.

March 26, 2014

Recent measles outbreaks in New York City and California have many healthcare professionals concerned for their patients. According to the Center for Disease Control, measles was declared eliminated from the United States in 2000, with only an average of 60 cases of measles reported each year. But in 2013, that number increased to 189 cases.